Johnson & Johnson Shares (Diluted) increased by 53056.5% to 2.4B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.9%, from 2.4B to 2.4B. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates potential dilution from employee compensation or convertible instruments, which can reduce earnings per share.
The weighted-average number of common shares outstanding plus the effect of all potentially dilutive securities, such as...
Standard metric for all public companies; essential for understanding the impact of equity-based compensation.
weighted_shares_diluted| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.6B | 2.6B | 2.5B | 2.4B | 2.4B | 2.4B | 2.4B | 2.4B | 2.4B | 4.6M | 2.4B |
| QoQ Change | — | +0.1% | -0.3% | +0.1% | -0.2% | -2.1% | +0.8% | -2.9% | -4.7% | -0.3% | +0.2% | -0.2% | -0.2% | +0.4% | -99.8% | >999% |
| YoY Change | — | — | — | -0.1% | -0.5% | -2.3% | -1.6% | -4.2% | -6.7% | -7.8% | -4.8% | -0.3% | -0.1% | +0.0% | — | +0.9% |